BDBM77603 2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(6-methoxypyridin-3-yl)acetamide::2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(6-methoxypyridin-3-yl)ethanamide::2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(6-methoxy-3-pyridinyl)acetamide::2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(6-methoxy-3-pyridyl)acetamide::MLS002169426::SMR001249763::cid_16311908

SMILES O=C(C1CN(CCCO)C1)N1CCC2CC1c1cc(-c3ccc(C(F)(F)F)cc3)ccc12

InChI Key InChIKey=AWRXSPQHWZZIHE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 77603   

TargetSigma intracellular receptor 2(Human)
University of Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 77603BDBM77603(US20250387403, Example Table1.18)
Affinity DataKi:  11.9nMAssay Description:Keywords: apoptosis, BH3 domain, Bcl2-A1, BIM, caspase, cancer Primary Collaborator: Todd Golub, Broad Institute, golub@broadinstitute.org Assay Over...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/6/2026
Entry Details
US Patent